Financial Analyst - Saudi National at GSK

GSK; Riyadh; On-site; SAR 120,000 - 180,000; Full time

Job summary

GSK Saudi Arabia is seeking a Financial Analyst to support end-to-end SG&A reporting, planning, and close processes. The role involves coordinating with the C&C HUB during monthly ME close, ensuring accurate accruals and insightful variance analyses, and partnering with commercial teams to develop financial plans.

Ideal candidates hold a Bachelor's in accounting/finance, are SOCPA members, and have 1–3 years of corporate finance experience, with fluency in English and Arabic and familiarity with

Qualifications

• Bachelor’s degree in accounting or finance.
• SOCPA membership mandatory.
• 1–3 years of corporate finance experience.
• Experience in pharmaceutical industry preferred.
• Fluency in English and Arabic.

Responsibilities

• Support end-to-end SG&A reporting and monitoring.
• Track budget vs actual P&L and provide monthly reports.
• Collaborate with C&C HUB during ME closing and planning cycles.
• Assist in financial planning, forecasts, and commentary submissions.
• Partner with commercial teams to develop financial plans.

Skills

Power BI

Advanced Excel

Financial analysis

Bilingual EN/AR

SOCPA Member

Education

Bachelor's degree in accounting/finance

Job description

GSK Saudi Arabia is committed to supporting Vision 2030 and the Saudi Arabian National Agenda including Saudization in line with the hiring and the training and development of Saudi National capability.

GSK Saudi Arabia is committed to supporting Vision 2030 and the Saudi Arabian National Agenda including Saudization in line with the hiring and the training and development of Saudi National capability.

Job Purpose The Financial Analyst will be responsible for supporting end-to-end reporting, tracking, and monitoring of SG&A spend. This includes monthly tracking of Advertising & Promotion (A&P) /Scientific Engagement (SE) spend activity by category, aligning with business and medical functions on YTD/YTG spend, with gap/phasing analysis. The role will involve working closely with the Close & Control (C&C) HUB during the ME closing and supporting the FBP in managing sign-off commentaries with the Planning HUB. The role will also support the FBP during the monthly close and control activities, primarily related to capturing accurate SG&A by ensuring strong alignment with the C&C HUB. This will ensure completeness of accruals and accuracy of numbers with respect to spend allocation across business units. Additionally, the Financial Analyst will support the Senior Finance Business Partner (SFP) during planning cycles to ensure accurate submission of financial plans, updates, forecasts, and all ancillary activities associated with the planning exercise. The role will involve close collaboration with the commercial team in developing financial plans and updates.

Key Responsibilities

Your Key Responsibilities This role will provide YOU the opportunity to lead key activities to progress YOUR career, these responsibilities include some of the following…

Reporting and Analysis

• Supervising close and control activities on profit and loss, monitoring budget vs actual P&L and submitting commentaries to regional teams.
• Providing visibility to the management on performance and spend by providing monthly and adhoc financial reports per requirement.
• Process improvement initiatives on all reporting and system automation to minimize manual work and efficient reporting that support decision making.

Business Partnering

• Carrying out all ancillary planning activities including and not limited to plan phasing (calendarization), exchange and cost flips, submission of plan in financial planning system, preparing GEM offline templates and presentations.
• Support Senior finance partner (SFP) in Core commercial cycle (CCC) with preparing summary for movements Vs. last cycles for SFP & FD ensuring active participation of finance by bringing in stock position, YTD / YTG growth, capturing market dynamics for competitive analysis etc.
• Tracking actual Gross-to-Net (G2N) reflections with focus analysis of variance Vs. plan and forecast (CCC).
• Reviewing SG&A aiming to make recommendations for cost savings.
• Supporting management / business units in provision of financials pertaining to business needs.
• Supporting and at times lead commercial initiatives to bring in operational efficiencies in SG&A.
• Be hands-on with analytical tools (Power BI etc.) to support core business team with data points and leads to action accordingly.

Why you?

• Saudi National.
• Bachelor’s degree of accounting or finance is required.
• SOCPA Member is mandatory.
• Preferred Finance qualification: SOCPA/CA/ACCA/CPA/CFA/CMA/CIMA.
• 1-3 years of corporate finance and/or Big 4 experience required.
• Experience in the pharmaceutical industry is preferred.
• Advanced excel and power point skills.
• Written and spoken fluency in English and Arabic.
• The Candidate Must be Located in Riyadh.
• Interpersonal skills Clear Communication : Strong verbal, written, and listening skills.
• Teamwork : Collaborative and goal oriented.
• Conflict Resolution : Diplomatic and empathetic.
• Adaptability : Flexible and relationship focused.
• Essential Skills and Abilities: Understanding of commercial operations, reporting, IFRS, auditing, FP&A and business partnering.

Closing date for applications: 14 October 2026

• Business Reporting Tools
• Data Storytelling
• Digital Fluency
• Financial Modeling
• Financial Performance Improvement
• Influencing Without Authority
• Insight Generation
• Problem Solving

Why GSK?

Uniting science, technology and talent to get ahead of disease together. GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale. People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.